Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AdaptHealth (AHCO) Change in Receivables (2019 - 2025)

Historic Change in Receivables for AdaptHealth (AHCO) over the last 7 years, with Q3 2025 value amounting to -$13.3 million.

  • AdaptHealth's Change in Receivables rose 6298.49% to -$13.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$8.2 million, marking a year-over-year decrease of 12644.26%. This contributed to the annual value of $26.2 million for FY2024, which is 916.43% down from last year.
  • Latest data reveals that AdaptHealth reported Change in Receivables of -$13.3 million as of Q3 2025, which was up 6298.49% from -$24.3 million recorded in Q2 2025.
  • AdaptHealth's Change in Receivables' 5-year high stood at $40.6 million during Q1 2024, with a 5-year trough of -$35.9 million in Q3 2024.
  • Its 5-year average for Change in Receivables is $3.3 million, with a median of $5.0 million in 2023.
  • Data for AdaptHealth's Change in Receivables shows a peak YoY increase of 172852.59% (in 2021) and a maximum YoY decrease of 580000.0% (in 2021) over the last 5 years.
  • Quarter analysis of 5 years shows AdaptHealth's Change in Receivables stood at $4.6 million in 2021, then tumbled by 44.79% to $2.6 million in 2022, then surged by 633.4% to $18.8 million in 2023, then fell by 26.07% to $13.9 million in 2024, then plummeted by 195.41% to -$13.3 million in 2025.
  • Its Change in Receivables was -$13.3 million in Q3 2025, compared to -$24.3 million in Q2 2025 and $15.4 million in Q1 2025.